⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Genesis MedTech Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Genesis MedTech Group
↗Singapore, Singapore
Genesis MedTech is a vertically integrated medical technology platform focused on emerging markets, particularly in the APAC region. The company operates by sourcing global medical technologies, developing them through in-house and partner R&D, and managing manufacturing and distribution across cardiovascular, neurovascular, and minimally invasive surgical device sectors.
The group maintains a robust infrastructure including R&D centers, advanced manufacturing facilities, and clinical training hubs. They provide comprehensive support services including regulatory strategy, market access, and commercial scale-up for medical device innovations.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Minimally invasive surgical devices, neurovascular, cardiovascular
SIZE & FINANCIALS
Employees:1001-5000
Ownership:private
Status:operating
FUNDING
Stage:Private Equity backed
Investors:General Atlantic
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Minimally invasive surgical devices, Interventional devices
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Genesis Medtech (Wuxi) Co., Ltd.
Key Partnerships:General Atlantic (Investor/Strategic Partner)
COMPETITION
Position:Challenger
Competitors:Medtronic, Boston Scientific
LEADERSHIP
Key Executives:
Wang Xin - Legal Representative (Wuxi Entity)
LINKS
Website:gmedtech.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Genesis MedTech Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.